Skip to content
Screener

Cytosorbents CTSO Q1 2026 Annual earnings

Reported May 13, 2026 · After market close

Revenue$8.9MMiss by $536.0K
EPS-$0.08Miss by $0.02
Revenue estimate$9.4M
EPS estimate-$0.06

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$9.9M
EPS estimate-$0.05

FAQ

When did Cytosorbents report Q1 2026 earnings?
Cytosorbents (CTSO) reported Q1 2026 earnings on May 13, 2026 after market close.
What were Cytosorbents's Q1 2026 revenue and EPS?
Cytosorbents reported revenue of $8.9M and eps of $-0.08 for Q1 2026.
Did Cytosorbents beat estimates in Q1 2026?
Revenue missed the consensus estimate of $9.4M by $536.0K. EPS missed the consensus estimate of $-0.06 by $0.02.
How did Cytosorbents's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1.6% from $8.7M a year earlier and eps declined 33.3% from $-0.06.
Where can I find Cytosorbents's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000929638-26-001834) and the 10-K/A periodic report (0001104659-26-043852) directly on SEC EDGAR. The filing index links above go to sec.gov.